Trial · NCT07885735
Assessment of Nutritional Status in Celiac Disease Using Muscle Ultrasound in Pediatric Patients.
NCT07885735, Not applicable, Enrolling by invitation, Ondokuz Mayıs University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Assessment of Nutritional Status in Celiac Disease Using Muscle Ultrasound in Pediatric Patients. Trials, record NCT07885735. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885735
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Assessment of Nutritional Status in Celiac Disease Using Muscle Ultrasound in Pediatric Patients.
- NCT number
- NCT07885735
- Status
- Enrolling by invitation
- Phases
- Not applicable
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Ondokuz Mayıs University
- Conditions
- Celiac Disease in Children, Nutritional Assessment
- Interventions
- performing muscle ultrasonography on patients
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Regional Muscle Thickness Measured by Ultrasonography in Children With Celiac Disease and Healthy Controls | At baseline (single assessment at study enrollment) | Regional muscle thickness will be measured in millimeters (mm) using B-mode ultrasonography in children diagnosed with celiac disease and healthy controls. Measurements will include the rectus abdominis, rectus femoris and biceps brachii muscles. Muscle thickness measurements will be recorded for each anatomical region and compared between the two groups. |
| Primary | Association Between Ultrasonographic Muscle Thickness and Anthropometric Z-Scores in Children With Celiac Disease | At baseline (single assessment at study enrollment) | the correlations between regional muscle thickness and anthropometric Z-scores will be reported in children with celiac disease. Muscle thickness of the rectus abdominis, rectus femoris, and biceps brachii will be measured in millimeters (mm) using B-mode ultrasonography. Nutritional status will be characterized using weight-for-age, height-for-age, and BMI-for-age Z-scores calculated from age-appropriate growth references. Associations will be reported as correlation coefficients (r or rho), with corresponding p-values. |
| Primary | Ultrasonographic Muscle Thickness According to Malnutrition Status in Children With Celiac Disease | At baseline (single assessment at study enrollment) | Regional muscle thickness will be measured in millimeters (mm) using B-mode ultrasonography in children with celiac disease. Measurements of the rectus abdominis, rectus femoris, and biceps brachii muscles will be compared between children with and without malnutrition. Malnutrition status will be classified according to predefined anthropometric Z-score criteria. Muscle thickness measurements will be reported separately for each group. |
| Primary | Ultrasonographic Muscle Thickness According to Gluten-Free Diet Adherence in Children With Celiac Disease | At baseline (single assessment at study enrollment) | Regional muscle thickness will be measured in millimeters (mm) using B-mode ultrasonography in children with celiac disease. Measurements of the rectus abdominis, rectus femoris, and biceps brachii muscles will be compared between patients classified as adherent and non-adherent to a gluten-free diet. Dietary adherence will be determined according to the predefined assessment criteria in the study protocol. Muscle thickness measurements will be reported separately for each group. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885735
GET https://conductscience.org/api/trials/v1/NCT07885735/registered